For instance, GPER may mediate the proliferative effects of estrogen in breast, endometrial, and in ovarian cancer cells in preclinical models (11), while other reports have shown a positive correlation of GPER expression with survival of patients with gastric and breast cancer (33, 34). Here, GPER1 is linked to ovarian carcinoma.